When Soft Tissue Turns to Bone
- Fibrodysplasia ossificans progressiva (FOP) is an ULTRA-RARE, AUTOSOMAL DOMINANT genetic disorder caused by a GAIN-OF-FUNCTION mutation in ACVR1 (ALK2) - the canonical R206H variant - which dysregulates BMP-type-I-receptor and ACTIVIN A signalling, causing progressive HETEROTOPIC OSSIFICATION (HO) that turns muscle, tendon, ligament and fascia into bone.
- There are TWO clinical hallmarks: (1) a congenital MALFORMATION OF THE GREAT TOES (short/valgus/monophalangic), present at BIRTH and the most penetrant feature - the diagnostic CLUE often visible before any HO; and (2) progressive HETEROTOPIC OSSIFICATION, which usually begins in early childhood as soft-tissue swellings ('flare-ups') that mature into bone.
- HO progresses in a characteristic ANATOMIC PATTERN - generally AXIAL to appendicular, CRANIAL to caudal, PROXIMAL to distal and DORSAL to ventral - and the flares are frequently TRIGGERED BY TRAUMA, including intramuscular INJECTIONS, BIOPSIES, SURGERY, dental/mandibular blocks, falls and viral illness.
- Because trauma triggers catastrophic HO, BIOPSY of a suspicious soft-tissue swelling is CONTRAINDICATED (the swelling is an FOP flare, NOT a tumour, and biopsy accelerates ossification), and INTRAMUSCULAR INJECTIONS and elective SURGERY (including excision of the heterotopic bone) must be AVOIDED - surgical excision of HO simply provokes more HO.
- DIAGNOSIS is CLINICAL - the combination of the malformed great toes and progressive soft-tissue ossification - and is confirmed by ACVR1 GENETIC testing; FOP is repeatedly MISDIAGNOSED as cancer or aggressive fibromatosis, leading to harmful biopsy, so recognising the great-toe clue is critical. Progressive joint ANKYLOSIS and costovertebral/thoracic ossification cause cumulative immobility and RESTRICTIVE LUNG disease (the main cause of death).
- There is NO cure: management is SUPPORTIVE and preventive - AVOID trauma/IM injections/surgery/biopsy, fall prevention, manage acute flares (high-dose corticosteroids for flares near major joints/the jaw, NSAIDs), dental care avoiding mandibular blocks, and respiratory monitoring; PALOVAROTENE (a retinoic-acid-receptor-gamma agonist) is approved to reduce HO, and Activin A-targeting and other agents are in development.
- “FOP = AD ACVR1 (ALK2) gain-of-function (R206H) -> Activin A-driven progressive heterotopic ossification (soft tissue -> bone).
- “Two hallmarks: congenital MALFORMED GREAT TOES (clue at birth) + progressive HO (axial->appendicular, proximal->distal).
- “TRAUMA triggers flares -> NO biopsy, NO IM injections, NO surgical excision of HO. Diagnose clinically + ACVR1; supportive care + palovarotene; restrictive lung disease = main cause of death.
A child with malformed great toes and soft-tissue swellings that turn to bone has FOP. The great- toe malformation is present at birth, before the heterotopic ossification.
Trauma triggers catastrophic HO - biopsy of the swelling, intramuscular injections and surgical excision of heterotopic bone all provoke more ossification. Diagnose clinically and avoid them.
Genetics & Pathophysiology
FOP is caused by an autosomal dominant gain-of-function mutation in ACVR1 (ALK2), a BMP type I receptor; the canonical mutation is R206H. The mutant receptor responds aberrantly to ACTIVIN A (which normally would not activate this pathway) and dysregulates BMP/SMAD signalling, so that, following an inflammatory/traumatic trigger, connective-tissue progenitor cells undergo a fibroproliferative -> chondrogenic -> osteogenic sequence that ends in mature heterotopic bone - effectively turning soft tissue into a second skeleton. This molecular understanding underlies the emerging therapies (Activin A antibodies, ALK2 inhibitors, the retinoic-acid-receptor-gamma agonist palovarotene).
Clinical Course & Diagnosis
The malformed great toes are present at birth and are the key early clue. HO typically begins in early childhood as painful soft-tissue swellings ('flare-ups') - often after trauma or illness - that mature into bone, progressing in a characteristic axial-to-appendicular, cranial-to-caudal, proximal-to-distal pattern. Over time, bridging HO across joints causes cumulative ANKYLOSIS and immobility, and costovertebral/thoracic ossification produces restrictive lung disease, which is the main cause of death. FOP is frequently MISDIAGNOSED as a tumour or aggressive fibromatosis - leading to a harmful biopsy
- so the diagnosis should be made CLINICALLY from the great-toe malformation plus progressive ossification and confirmed by ACVR1 genetic testing, NOT by biopsy.
Management
- Avoid triggers: NO biopsy, NO intramuscular injections, NO elective surgery (including excision of heterotopic bone, which provokes more HO); avoid mandibular dental blocks; prevent falls; use intravenous/subcutaneous rather than IM medication routes.
- Acute flares: high-dose corticosteroids for flares involving major joints, the jaw or other critical areas, plus NSAIDs/symptom control.
- Disease-modifying: PALOVAROTENE (a retinoic-acid-receptor-gamma agonist) is approved to reduce new HO; Activin A-targeting antibodies and ALK2 inhibitors are in development.
- Supportive/MDT: respiratory monitoring and care (restrictive disease), dental care without IM blocks, occupational therapy/mobility aids, fall prevention, and anaesthetic precautions (difficult airway from cervical/jaw ankylosis - avoid IM injections and forced neck manipulation).
- Counselling: autosomal dominant inheritance and genetic counselling.
The single most important and exam-critical message is that in FOP, TRAUMA causes catastrophic heterotopic ossification, so a soft-tissue swelling must NOT be biopsied (it is a flare, not a tumour), intramuscular injections must be avoided, and the heterotopic bone must NOT be surgically excised because excision provokes even more ossification. The diagnosis is made clinically from the pathognomonic malformed great toes and progressive ossification and confirmed by ACVR1 genetic testing. Anaesthesia is hazardous because of cervical- spine and jaw ankylosis and restrictive lung disease, so any unavoidable procedure needs careful planning with avoidance of intramuscular injections, intubation trauma and forced manipulation.
Evidence & Key Studies
Molecular developmental biology of FOP: ACVR1, the great toe and skeletal patterning
- Heterotopic ossification is the most prominent feature of FOP, which is caused by missense mutations in ACVR1.
- The mutation affects skeletal development even before HO appears, producing the signature malformation of the great toes (the most penetrant phenotype).
- Other skeletal features include joint malformation and ankylosis (cervical spine, costovertebral joints) and characteristic facial features.
MMP-9 deficiency confers resilience in FOP (ACVR1 R206H, Activin A and trauma-triggered HO)
- FOP is driven by the canonical pathogenic ACVR1 R206H variant with the classic congenital great-toe malformation.
- Activin A is an obligate ligand for heterotopic ossification, and trauma/inflammation trigger HO - linking inflammation to ossification.
- Molecular dissection of an unusually resilient patient identified MMP-9 as a druggable node linking inflammation to HO, illustrating the trauma-inflammation-HO axis.
According to PubMed, the ACVR1 basis, the signature great-toe malformation (most penetrant, present before HO) and the associated joint ankylosis come from the cited Towler review, and the R206H variant, the obligate role of Activin A and the trauma/inflammation trigger for HO from the cited Lounev study. The autosomal-dominant inheritance, the progressive ossification pattern, the contraindication to biopsy/IM injection/surgery, and the supportive management (including palovarotene) are standard, well-established teaching. (See also our Heterotopic Ossification and Skeletal Dysplasias topics.)
Clinical Decision Scenarios
Practise clinical reasoning and management decisions out loud
“A child has malformed great toes and develops painful soft-tissue swellings that harden into bone. What is the diagnosis, the genetics, and the one thing you must NOT do?”
“How is FOP managed, and what causes death?”
Mnemonics & Memory Aids
FOP
Hook:FOP: malformed First toes, Ossifying soft tissue, Procedures forbidden.
NO TRAUMA
Hook:In FOP, avoid all TRAUMA - it triggers ossification.
Genetics & pathophysiology
- Autosomal dominant ACVR1 (ALK2) gain-of-function (R206H)
- Aberrant Activin A/BMP-SMAD signalling -> heterotopic ossification
- Soft tissue (muscle/tendon/ligament/fascia) -> bone
Two hallmarks
- Congenital MALFORMED GREAT TOES (at birth - the clue)
- Progressive heterotopic ossification (flares)
- Pattern: axial->appendicular, cranial->caudal, proximal->distal
Diagnosis & pitfalls
- CLINICAL (great toes + progressive HO) + ACVR1 genetics
- Trauma triggers HO: NO biopsy, NO IM injections, NO surgery/excision of HO
- Often misdiagnosed as cancer/fibromatosis (avoid harmful biopsy)
Management & prognosis
- Avoid triggers; high-dose steroids for flares; palovarotene reduces HO
- Respiratory care, dental care (no mandibular blocks), anaesthetic precautions
- Death usually from restrictive lung disease / thoracic insufficiency